Tolerance to solid organ transplants through transfer of MHC class II genes
AUTOR(ES)
Sonntag, Kai-C.
FONTE
American Society for Clinical Investigation
RESUMO
Donor/recipient MHC class II matching permits survival of experimental allografts without permanent immunosuppression, but is not clinically applicable due to the extensive polymorphism of this locus. As an alternative, we have tested a gene therapy approach in a preclinical animal model to determine whether expression of allogeneic class II transgenes (Tg’s) in recipient bone marrow cells would allow survival of subsequent Tg-matched renal allografts. Somatic matching between donor kidney class II and the recipient Tg’s, in combination with a short treatment of cyclosporine A, prolonged graft survival with DR and promoted tolerance with DQ. Class II Tg expression in the lymphoid lineage and the graft itself were sequentially implicated in this tolerance induction. These results demonstrate the potential of MHC class II gene transfer to permit tolerance to solid organ allografts.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=198548Documentos Relacionados
- Autoreactive T cells can be protected from tolerance induction through competition by flanking determinants for access to class II MHC
- Mice lacking all conventional MHC class II genes
- Health care-related infections in solid organ transplants
- MHC class II presenting cells are necessary for the induction of intrathymic tolerance.
- Two Mhc class I and two Mhc class II genes map to the chicken Rfp-Y system outside the B complex.